TECHNOLOGY and PIPELINE

Overview

NanoMab is developing next generation radiopharmaceuticals for cancer precision medicine to be used in conjunction with the established global network of PET facilities. Our goal is to develop a pipeline of theranostic couple camelid antibodies with our proprietary camelid antibodies platform to address the unmet diagnostic and medical need for cancer patients in the world.

Read About Our Platforms
Read About Our Pipeline

CONTACT US

Please do not hesitate to contact us with any questions about our technology or pipeline.

CONTACT US TO LEARN MORE